Page last updated: 2024-08-25

zoledronic acid and Hematologic Malignancies

zoledronic acid has been researched along with Hematologic Malignancies in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Felsenberg, D; Gabbert, TI; Hoffmeister, B1
Chae, YS; Kim, JG; Kim, SN; Kim, YJ; Lee, SJ; Moon, JH; Sohn, SK1
Lortholary, A1

Reviews

1 review(s) available for zoledronic acid and Hematologic Malignancies

ArticleYear
[Tumor-induced hypercalcemia. Review of bisphosphonate treatment].
    La Revue de medecine interne, 2001, Volume: 22, Issue:7

    Topics: Diagnosis, Differential; Diagnostic Errors; Diphosphonates; Etidronic Acid; Fluid Therapy; Hematologic Neoplasms; Humans; Hypercalcemia; Imidazoles; Neoplasms; Pamidronate; Prognosis; Recurrence; Sodium Chloride; Treatment Outcome; Zoledronic Acid

2001

Trials

1 trial(s) available for zoledronic acid and Hematologic Malignancies

ArticleYear
Pilot study on the use of zoledronic acid to prevent bone loss in allo-SCT recipients.
    Bone marrow transplantation, 2009, Volume: 44, Issue:1

    Topics: Adolescent; Adult; Aged; Bone Density; Bone Density Conservation Agents; Chronic Disease; Diphosphonates; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Imidazoles; Male; Middle Aged; Osteoporosis; Pilot Projects; Stem Cell Transplantation; Steroids; Transplantation, Homologous; Zoledronic Acid

2009

Other Studies

1 other study(ies) available for zoledronic acid and Hematologic Malignancies

ArticleYear
Risk factors influencing the duration of treatment with bisphosphonates until occurrence of an osteonecrosis of the jaw in 963 cancer patients.
    Journal of cancer research and clinical oncology, 2015, Volume: 141, Issue:4

    Topics: Aged; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Disease-Free Survival; Female; Germany; Hematologic Neoplasms; Humans; Ibandronic Acid; Imidazoles; Jaw Diseases; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Middle Aged; Multiple Myeloma; Neoplasms; Osteonecrosis; Pamidronate; Prostatic Neoplasms; Registries; Risk Factors; Sex Factors; Time Factors; Zoledronic Acid

2015